In summary, our study suggests that the CBFβ-MYH11 fusion maintains inv(16) AML cells by attenuating expression levels of GATA2 and blocks their further differentiation towards Mega/Ery lineages via interfering with a GATA2/KLF1-involved regulatory network. This evidence concerns the gene CBFB and acute myeloid leukemia.